JCO Precis Oncol
Dr. Arvinda Padmanabhan, MD
- Medicare services, 2024
- 983
- Medicare patients, 2024
- 340
- Part D claims, 2024
- 2,462
- Publications
- 2
- Clinical trials
- 7
- Practice address
- 801 Eastern Bypass, Richmond, KY 40475
- Practice phone
- Call (859) 625-3114
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Padmanabhan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Arvinda Padmanabhan is a medical oncologist in Richmond, Kentucky
Dr. Padmanabhan practices at Baptist Health Richmond in Richmond, Kentucky, part of Baptist Health.
Dr. Padmanabhan's NPI, 1629280656, was assigned on May 3, 2007. Dr. Padmanabhan graduated from University of Kentucky College of Medicine in 2004. Dr. Padmanabhan holds Kentucky license 41739.
- NPI
- 1629280656NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4486822541
- NPI enumeration date
- May 3, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (859) 625-3114
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Arvinda Padmanabhan practices at Baptist Health Richmond in Richmond, Kentucky
Dr. Padmanabhan's primary practice is Baptist Health Richmond, at 801 Eastern Bypass, Richmond, KY 40475 in Madison County. The practice phone is (859) 625-3114.
- Baptist Health Richmond801 Eastern Bypass, Richmond, KY 40475 · Madison CountyPhone(859) 625-3114
Source: Dmand AI Affiliation Data
Dr. Arvinda Padmanabhan is affiliated with 5 sites of care and 2 medical groups
Dr. Padmanabhan's primary practice is Baptist Health Richmond in Richmond, Kentucky, part of Baptist Health. Dr. Padmanabhan is also affiliated with Baptist Health Lexington. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Padmanabhan to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Arvinda Padmanabhan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padmanabhan practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Baptist Health Richmond | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Baptist Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Arvinda Padmanabhan is one of 50 medical oncologists in Kentucky
Medical oncology is Dr. Padmanabhan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Padmanabhan is licensed in Kentucky.
Specialties and state licenses
- Medical oncology, KentuckyPrimary
Medical oncologists near Dr. Padmanabhan
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Arvinda Padmanabhan billed Medicare for 983 services in 2024
CMS data shows 983 Medicare services from Dr. Padmanabhan across 10 procedure codes in 2024, for 340 Medicare patients. Medicare paid $86,052 for them.
Dr. Padmanabhan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9072024: 9394%
- Other services
- 2023: 02024: 44
Where Dr. Padmanabhan's Medicare services took place, 2024
- In an office89391%
- In a facility909%
Dr. Padmanabhan compared with the Kentucky median for medical oncologists, 2024
- Dr. Padmanabhan
- Kentucky median
- Medicare services
- 983vs 60064% above
- Medicare patients
- 340vs 22650% above
- Part D claims
- 2,087vs 5983.5 times
Medians across 56 medical oncologists in Kentucky with Dmand AI profiles that report each measure.
Dr. Padmanabhan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Padmanabhan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Padmanabhan and other medical oncologists in Kentucky.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Arvinda Padmanabhan treated 340 Medicare patients in 2024, average age 75
CMS counts 340 Medicare patients who saw Dr. Padmanabhan in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Padmanabhan's median patient age at 68, with 55% women.
Dr. Padmanabhan's Medicare patients by age, 2024
Dr. Padmanabhan's Medicare patients by sex, 2024
- Women16749%
- Men17351%
Chronic conditions among Dr. Padmanabhan's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis48%
- Cancer41%
- Ischemic heart disease38%
- Diabetes33%
- Anxiety31%
- Chronic kidney disease29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Padmanabhan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women55%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Arvinda Padmanabhan wrote 2,462 Medicare Part D claims in 2024
In 2024, Dr. Padmanabhan wrote 2,462 Medicare Part D claims for 355 patients. 71% of them were for generic drugs. CMS names the drug for 2,087 of them, across 63 drugs with 11 or more claims each, at $7,244,743 in total drug cost. In 2023, CMS named 1,989 claims across 59 drugs.
Dr. Padmanabhan's Part D claims by kind of drug, 2024
- Generic1,758 claims71%
- Brand-name and other704 claims29%
Dr. Padmanabhan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Padmanabhan's Part D claims, 2024
- Opioids6%160 of 2,462 claims
- Antibiotics4%100 of 2,462 claims
- Antipsychotics, patients 65 and over2%46 of 2,462 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,9892024: 2,0875%
Drugs named by CMS: 63 in 2024, 59 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Arvinda Padmanabhan scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Padmanabhan for performance year 2024, reported through an alternative payment model (APM). Dr. Padmanabhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Padmanabhan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Padmanabhan's MIPS scores, performance year 2024
- 94of 100Final score
- 87.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Arvinda Padmanabhan has 2 publications on record
Dmand AI links 2 papers to Dr. Padmanabhan, published from 2019 to 2021. Dr. Padmanabhan's most frequent co-authors are Christina Ellen Brzezniak, DO, Mark Edward Burkard, MD and Elizabeth C. Dees, MD.
Dr. Padmanabhan's most frequent co-authors
- Christina Ellen Brzezniak, DO1 shared paper
- Mark Edward Burkard, MD1 shared paper
- Elizabeth C. Dees, MD1 shared paper
Recent publications by Dr. Padmanabhan
See who Dr. Padmanabhan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Padmanabhan works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Arvinda Padmanabhan has worked on 7 clinical trials
Dmand AI links Dr. Padmanabhan to 7 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Carcinoma, Non-Small-Cell Lung and Carcinoma, Small Cell. Exact Sciences Corporation sponsors the most, 2.
Clinical trials with Dr. Padmanabhan by phase
- 1Phase 1: 1 trial
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Padmanabhan's trials
- Glioblastoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Gliosarcoma
- Hematologic Neoplasms
Investigators on the most trials with Dr. Padmanabhan
- Samir Mukundray Dalia, MD3 shared trials
- Abderrahim Khomani, MD3 shared trials
- Nicholas Michael Lopez, MD3 shared trials
Recent clinical trials with Dr. Padmanabhan
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Arvinda Padmanabhan received $18,767 in industry payments from 2016 to 2025
CMS Open Payments shows 750 general payments to Dr. Padmanabhan from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Merck Sharp & Dohme Corporation paid the most, $2,792.
General payments to Dr. Padmanabhan by program year, 2016 to 2025
General payments to Dr. Padmanabhan by kind, 2016 to 2025
- Food and beverage$17,54093%
- Travel and lodging$9585%
- Education$2681%
Companies that paid Dr. Padmanabhan the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Arvinda Padmanabhan graduated from University of Kentucky College of Medicine
Dr. Padmanabhan graduated from University of Kentucky College of Medicine in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Arvinda Padmanabhan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Arvinda Padmanabhan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Arvinda Padmanabhan's NPI number?
Dr. Arvinda Padmanabhan's NPI number is 1629280656. It was assigned on May 3, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Arvinda Padmanabhan?
Dr. Arvinda Padmanabhan is a medical oncologist in Richmond, Kentucky. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Arvinda Padmanabhan practice?
Dr. Padmanabhan practices at 801 Eastern Bypass, Richmond, KY 40475. Dr. Padmanabhan's primary practice is Baptist Health Richmond in Richmond, Kentucky, part of Baptist Health. Dmand AI also links Dr. Padmanabhan to 1 hospital, 2 group practices and clinics and 1 medical group.
What is Dr. Arvinda Padmanabhan's office phone number?
The practice phone on file for Dr. Padmanabhan is (859) 625-3114.
What is Dr. Arvinda Padmanabhan's medical license number?
Dr. Padmanabhan holds Kentucky license 41739.
Which hospitals is Dr. Arvinda Padmanabhan affiliated with?
Dr. Padmanabhan practices at Baptist Health Richmond in Richmond, Kentucky. Dr. Padmanabhan is also affiliated with Baptist Health Lexington. Dmand AI links Dr. Padmanabhan to 1 more hospital.
What medical group is Dr. Arvinda Padmanabhan part of?
Dr. Padmanabhan is linked to Baptist Health Medical Group. Dmand AI links Dr. Padmanabhan to 1 more medical group.
Does Dr. Arvinda Padmanabhan accept Medicare?
Yes. CMS data shows Dr. Padmanabhan billed Medicare for 983 services in 2024, and Dr. Padmanabhan accepts Medicare assignment.
Does Dr. Arvinda Padmanabhan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Padmanabhan as offering telehealth services.
What is Dr. Arvinda Padmanabhan's MIPS score?
Dr. Padmanabhan's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Arvinda Padmanabhan see?
CMS counts 340 Medicare patients who saw Dr. Padmanabhan in 2024, with an average age of 75.
What services does Dr. Arvinda Padmanabhan bill to Medicare?
In 2024, Dr. Padmanabhan's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).
Where did Dr. Arvinda Padmanabhan go to medical school?
Dr. Padmanabhan graduated from University of Kentucky College of Medicine in 2004.
What drugs does Dr. Arvinda Padmanabhan prescribe most?
In 2024 Medicare Part D data, Dr. Padmanabhan's most prescribed drugs by claims were Ondansetron HCl, Dexamethasone and Acyclovir.
Has Dr. Arvinda Padmanabhan received payments from drug or device companies?
CMS Open Payments shows $18,767 in general payments to Dr. Padmanabhan from 62 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Arvinda Padmanabhan been practicing?
Dr. Padmanabhan graduated from medical school in 2004, 22 years ago.
Does Dr. Arvinda Padmanabhan do research?
Dmand AI links 2 publications to Dr. Padmanabhan, published from 2019 to 2021. Dr. Padmanabhan has worked on 7 clinical trials.
Who does Dr. Arvinda Padmanabhan publish with?
Dr. Padmanabhan's most frequent co-authors are Christina Ellen Brzezniak, DO (1 shared paper), Mark Edward Burkard, MD (1 shared paper) and Elizabeth C. Dees, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Kentucky by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card